Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.52 USD | +1.10% | -11.89% | +67.47% |
Evolution of the average Target Price on Rani Therapeutics Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Rani Therapeutics Holdings, Inc.
UBS | |
HC Wainwright | |
Canaccord Genuity | |
Wedbush | |
BTIG | |
Cantor Fitzgerald | |
Stifel Nicolaus | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- RANI Stock
- Consensus Rani Therapeutics Holdings, Inc.